Skip to content
healthcare.dev

SPEVIGO

NDC 50222-361, spesolimab, injection, from LEO Pharma Inc..

Product NDC
50222-361
Status
Listed
Labeler
LEO Pharma Inc.
Dosage form
INJECTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761244
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50222-361 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SPESOLIMAB150 mg/mL

Pharmacologic classes

Interleukin-36 Receptor Antagonist [EPC]; Interleukin-36 Receptor Antagonists [MoA]

Package NDCNDC-11Package
50222-361-02502220361022 SYRINGE, GLASS in 1 CARTON (50222-361-02) / 1 mL in 1 SYRINGE, GLASS (50222-361-11)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/78a4f7eb-8d34-4467-8d40-74ed24323806

Use it

Look up 50222-361 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50222-361 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50222-361. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.